RE:RE:RE:RE:RE:RE:RE:RE:Great NewsHempdoc wrote: Enrique wrote:
"Not really, as all 8 regardless of category will get retreated with 2nd treatment. Only patients who show cancer progression from now on will be removed from trial and not retreated. All others will get 2nd treatment so could be any of the 3 categories of patients who showed a response or who show CIS with no progression. From my understanding."
That is the correct interpretation Enrique...& as you say, any patient who shows either "unchanged or worsening" CIS "without" evidence of either MIBC or metastatic disease will be eligible for a 2nd treatment.
Ok, wow. So very few patients then will be excluded going forward. Assuming TLT got dosing correct at the end of Phase 1, and now have a working model for how to measure the bladder volume. Bodes well for this Phase 2 once completed.